Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Cancer Metastatic × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 44 Breast Neoplasms 31 Ovarian Neoplasms 27 Triple Negative Breast Neoplasms 19 Endometrial Neoplasms 19 Stomach Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 16 Esophageal Neoplasms 15 Fallopian Tube Neoplasms 14 Neoplasms 13 Neoplasm Metastasis 11 Esophageal Squamous Cell Carcinoma 11 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Carcinoma, Ovarian Epithelial 10 Uterine Cervical Neoplasms 9 Head and Neck Neoplasms 9 Colorectal Neoplasms 6 Recurrence 5 Melanoma 5 Carcinoma, Squamous Cell 5 Adenocarcinoma Of Esophagus 5 Carcinoma, Transitional Cell 4 Carcinoma 4 Uterine Neoplasms 3 Small Cell Lung Carcinoma 3 Oropharyngeal Neoplasms 3 Carcinoma, Renal Cell 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3

Interventions

Gemcitabine 2 toripalimab 1 surufatinib 1 Paclitaxel 1 Injections 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06752811 2026-02-10

pompom

Shanghai Yizhong Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡